Home » Newsletters » BioWorld Asia

BioWorld Asia

March 11, 1998

View Archived Issues

Transgène Seeks FFr420M In IPOs In France, US

bi03111998c.html

Trinity Turns Loss To Revenue; Buyouts Helped Bottom Line

Center Studying Vaccines For Rheumatic Fever, Malaria

Cantab's Revenues Double; R&D Program Set To Expand

Glaxo, Thallia Teaming Up For Microalgae-Based Drugs

PPL Expresses Blood-Clotting Agent In Transgenic Sheep Milk

Chinese Study Horse Drug As Human AIDS Vaccine

Amgen Supporting Cell Therapy Laboratory In France

EU 'Closely Follows' Ethics Of Gene-Based Diagnostics

Chiroscience Spins Off DNA Analysis Subsidiary

Agen Rebuffs A$16M Takeover Move By Biotech International

EU May Lend Support To Added Worldwide Rules On Cloning

British Biotech Losses 'In Line With Plan'

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...